Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Ebola: Sierra Leone Officials Criticize Travel Relaxation

By Drug Discovery Trends Editor | February 3, 2015

Although Ebola cases are declining in West Africa, Sierra Leone officials are worried that the president’s decision to lift travel restrictions may re-ignite the spread of the deadly disease.

President Ernest Bai Koroma two weeks ago announced a relaxation of travel restrictions to support economic activity. Some officials agreed that the closure of roads hurt the economy. Others felt it was too soon.

“It was slightly too early,” Freetown Mayor Franklyn Bode Gibson said Tuesday. “We do not know who is safe and who is not,” and a second outbreak of the disease would be distrastrous.

Gibson said Tuesday he will call for a meeting this week with the National Ebola Response Center to register his disappointment about the re-opening of district roads.

The chairman of the eastern Kenema District, Dr. Senesie Mansaray, said the move to lift travel restrictions is “a serious blunder at this point in time.” He said that Bai Koroma should have waited until the end of February or March, while observing the trend of the spread of the virus, to put more mechanisms in place before lifting bans. The Kenema district recorded no new cases in the latest government figures.

The three most affected countries – Guinea, Sierra Leone and Liberia – appear to be making strides against the Ebola epidemic first identified last March. The U.N. health agency said last week that the countries had reported fewer than 100 cases in the past week, for the first time since June. Nearly 9,000 people have died from the virus spread through contact with bodily fluids.

Fears are “legitimate” according to opposition party publicity secretary Tamba Samba, but he added that the closure of the roads had hurt the economy.

Ibrahim Bundu, the leader of the governing All People’s Congress, said on a radio discussion that the decision to lift the travel ban was made to “boost the country’s Ebola defunct economy.”

Koroma has set a goal of zero cases by the end of March.

Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE